However, a recent in vivo study showed the effective, neutrophil-mediated killing of B16 melanoma cells when combining an IgG antibody targeting gp75 (a protein expressed on B16 melanoma cells), an CD40 antagonist and TNF [191]. This evidence concerns the gene TNF and melanoma.